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Repetitive transcranial magnetic stimulation (rTMS) of the temporal cortex has been used to treat patients with subjective tinnitus.
While rTMS is known to induce morphological changes in healthy subjects, no study has investigated yet whether rTMS treatment
induces grey matter (GM) changes in tinnitus patients as well, whether these changes are correlated with treatment success, and
whether GM at baseline is a useful predictor for treatment outcome. Therefore, we examined magnetic resonance images of 77
tinnitus patients who were treated with rTMS of the left temporal cortex (10 days, 2000 stimuli/day, 1 Hz). At baseline and after
the last treatment session high-resolution structural images of the brain were acquired and tinnitus severity was assessed. For a
subgroup of 41 patients, additional brain scans were done after a follow-up period of 90 days. GM changes were analysed by means
of voxel based morphometry. Transient GM decreases were detectable in several brain regions, especially in the insula and the
inferior frontal cortex. These changes were not related to treatment outcome though. Baseline images correlated with change in
tinnitus severity in the frontal cortex and the lingual gyrus, suggesting that GM at baseline might hold potential as a possible
predictor for treatment outcome.
1. Introduction
Subjective tinnitus is the phantom perception of a sound
in the absence of a corresponding objective sound source.
With about 25% of adults in the US having experienced
a ringing in the ears at least once [1], transient tinnitus
is a common phenomenon. About 10–15% of the world
population experience tinnitus in its chronic form [2]. While
the majority of those 10–15% gets used to their tinnitus
and is able to lead a normal life, in 1–3% of the general
population tinnitus is experienced as extremely bothersome
and debilitating. It can severely affect patients’ everyday
lives and is often accompanied by psychiatric comorbidities
such as depressive syndromes or sleep disturbances [2, 3].
In order to improve existing treatment options and also to
generate new treatment strategies for subjective tinnitus, it is
mandatory to broaden knowledge on the neural mechanisms
underlying the tinnitus percept.
More than 15 years ago it has been suggested [4, 5] and
demonstrated [6] that tinnitus is related to alterations in
the central nervous system. Furthermore, recent functional
neuroimaging studies suggest [7–10] that, apart from the
auditory cortex, widespread neural networks involving many
different brain areas seem to be involved in the generation and
maintenance of the phantom sounds as well as in the distress
accompanied by the tinnitus percept [11, 12]. In addition
to functional alterations within the brain, tinnitus has also
been shown to be related to structural brain changes [13].
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Studies using high-resolution magnetic resonance imaging
(MRI) to compare the grey matter (GM) volume and cortical
thickness of tinnitus patients with healthy control subjects
have revealed alterations in the auditory cortex [14–16] and
in subcortical parts of the central auditory pathway like
the thalamus [17] and the right inferior colliculus [18].
Furthermore, alterations in grey matter volume and cortical
thickness were also found in nonauditory brain locations
[15, 17–21].
The knowledge that subjective tinnitus is associated with
neural alterations suggests the therapeutic use of brain stim-
ulation techniques such as repetitive transcranial magnetic
stimulation (rTMS). The early finding that the auditory
cortex is overly active in tinnitus patients [6] led to the
idea of using low-frequency repetitive transcranial magnetic
stimulation to modify the cortical hyperactivity in patients
with phantom sounds [22]. Ever since then low-frequency
rTMS has been investigated in an increasing number of
studies (for a review, see [23]) showing that rTMS is effective
with high interindividual variability. However, it is still
difficult to identify predictors for treatment success [24].
The idea to use and improve rTMS as a treatment for
tinnitus is further pursued though. To gain deeper insight
into the mechanisms of rTMS treatment —and consequently
to facilitate improvement of the therapeutic approach—
the complementary use of both longitudinal neuroimaging
and clinical assessment to measure rTMS effects in tinnitus
patients is an important next step in tinnitus research [25].
The number of studies addressing this issue is limited so far.
Some studies investigated the effect of low-frequency rTMS
treatment on auditory evoked potentials and auditory steady
state responses using electro- and magnetoencephalogra-
phy (EEG/MEG) [26–28]. Two studies using single-photon
emission computed tomography and functional magnetic
resonance imaging (fMRI) found changes of neural activity
in the temporal lobe, the right cingulate gyrus, and the
uncus [26, 29].While those studies have provided first insight
in the functional alterations that are associated with low-
frequency rTMS of the auditory cortex, there is no study
which adds knowledge about structural alterations induced
by rTMS treatment in tinnitus patients. Until now, only one
study examined the effect of low-frequency rTMS over the
left auditory cortex in healthy subjects using voxel based
morphometry (VBM) [30]. The results suggest that five days
of rTMS treatment leads to GM changes in the auditory
cortex and the thalamus.
Based on all those results the current studywas conducted
with the following three research questions in mind: (1) is
there a change in grey matter detectable in tinnitus patients
after 10 sessions of rTMS treatment and after a follow-
up period of 90 days? (2) Is there a relationship between
the clinical outcome and the grey matter changes? (3) Can
structural imaging be used as a predictor for outcome? To
answer these questions we evaluated MRI scans of patients
suffering from subjective tinnitus which were done routinely
before and after low-frequency rTMS of the temporal cortex.
2. Materials and Methods
2.1. Subjects. Data from 77 patients (59 male, 18 female)
with chronic tinnitus were included in the analyses. Patients
with cardiac pacemakers, history of seizures, or any severe
somatic, neurologic, or psychiatric disorder were excluded.
The decision whether a patient was suffering from any severe
somatic, neurologic, or psychiatric disorder was made by
the physician, who decided about study inclusion based on
the global clinical impression. One criterion for a severe
somatic, neurologic, or psychiatric disorder was the need
for an immediate therapeutic action for the treatment of
this disorder. Another criterion was current hospitalization
because of such disorder.
All patients were treated with rTMS and underwent MRI
scanning before (baseline) and after (day 12) ten sessions of
rTMS treatment. In a subgroup of 41 patients, an additional
measurement was done after a follow-up period of three
months (day 90).The total sample of 77 patients was therefore
divided into two independent subgroups of one sample with
two scans (𝑛 = 36) and one sample with three scans
(𝑛 = 41). Demographical and clinical characteristics for
both subgroups are shown in Table 1. Audiological data and
a measure of hyperacusis were not available for all patients
and could therefore not be included in the further analyses.
Standardized pure tone audiometry data was available for
57 patients and revealed a mean hearing loss of 20.38 ±
12.14 [dB HL] (average of all thresholds measured bilaterally
ranging from 125Hz to 8 kHz). As a screening measure of
hyperacusis, patients were asked whether “sounds cause pain
or physical discomfort” [31]. Of the 61 patients who answered
this question, 35 said “yes” and are therefore supposed to
suffer from hyperacusis. Independent samples 𝑡-tests and
Chi2-tests revealed no significant difference between the two
independent subgroups concerning all variables reported in
Table 1.
2.2. Repetitive Transcranial Magnetic Stimulation. rTMS
treatment consisted of 10 treatment sessions on 10 consecutive
working days. Patients were treated in the context of several
clinical trials [32–34] or rTMSwas done as compassionate use
treatment between 2006 and 2009. Patients were stimulated
over the left temporal cortex (1Hz, 2000 stimuli/day, 110%
resting motor threshold) which was localized either by using
a standard procedure targeting the primary auditory cortex
based on the 10–20 system [35, 36] or by using neuron-
avigation based on individual MRI/PET (positron emission
tomography) images. In the latter cases, the area of increased
activation within the primary auditory cortex was used as
target area. Even if these two methods may have resulted
in slightly different targets, the spatial difference is smaller
than the spatial accuracy of rTMS treatment with the used
figure-of-eight coil. For rTMS treatment, a Medtronic system
with a figure-of-eight coil was used (90mm outer diameter;
Medtronic, Minneapolis, MN). The coil was held with a
mechanical arm and placed over the left temporal cortex with
the handle of the coil pointing upwards. During treatment,
the patients were seated in a comfortable treatment chair.The
resting motor threshold was measured once before the first
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Table 1: Demographical data and clinical characteristics for both independent subgroups.
VBM data at baseline, day 12, and day 90
(𝑛 = 41)
VBM data at baseline and day 12
(𝑛 = 36)
Group comparison
𝑃 value
Gender 32m (78%)9 f (22%)
27m (75%)
9 f (25%) 𝜒
2(1.77) = 0.10 0.752
Age (years) 50.72 ± 13.37 50.79 ± 13.28 𝑇(75) = −0.02 0.983
Tinnitus laterality
10% right
15% left
75% bilateral
14% right
14% left
72% bilateral
𝜒
2(2.77) = 0.32 0.853
Tinnitus duration (years) 8.97 ± 8.36 7.57 ± 6.74 𝑇(75) = 0.80 0.427
TQ (baseline) 36.61 ± 17.78 39.56 ± 18.21 𝑇(75) = −0.72 0.476
Loudness (baseline) 6.32 ± 2.04 6.00 ± 2.11 𝑇(75) = 0.67 0.441
Mean hearing threshold
[dB HL]
21.67 ± 11.49
(𝑁 = 29)
19.06 ± 12.85
(𝑁 = 28) 𝑇(55) = 0.81 0.421
Hyperacusis 51% (𝑛 = 39) 68% (𝑛 = 22) 𝜒2(2.61) = 2.31 0.316
TQ: Tinnitus Questionnaire.
Loudness: how STRONG or LOUD is tinnitus at present (0 not at all, 10 extremely strong or loud).
Mean hearing threshold: average of all thresholds measured bilaterally ranging from 125Hz to 8 kHz).
treatment session and was defined as the minimal intensity at
which at least four out of eightmagnetically evoked potentials
were ≥50𝜇V in amplitude in the right abductor digiti minimi
muscle [37]. All patients were treated at the Tinnitus Centre at
theUniversity of Regensburg,Germany, andprovidedwritten
informed consent.The treatment protocol has been approved
by the local ethics committee.
2.3. Clinical Assessment. For the assessment of demograph-
ical and clinical characteristics, the Tinnitus Sample Case
History Questionnaire was used [38]. Tinnitus severity was
assessed using the German version of the Tinnitus Ques-
tionnaire (TQ [39, 40]) and a numeric rating scale, which
measured how loud the tinnitus was perceived (How strong
or loud is your tinnitus at present?).This scale was rated from
0 (not loud at all) to 10 (extremely strong or loud). These
measures were assessed before the first treatment session
(baseline), after the last treatment session (day 12), and—
for the subgroup of 41 patients with three images—after the
follow-up period of three months (day 90).
2.4. Magnetic Resonance Imaging. A Siemens Sonata 1.5 Tesla
whole body scanner (Siemens AG, Erlangen) with a stan-
dard 8-channel birdcage head coil was used to collect the
anatomical images. For each subject and each time point,
a high-resolution T1-weighted image was acquired using
a magnetization-prepared-rapid-acquisition-gradient-echo-
(MP-RAGE-) sequence (repetition time 1880ms; echo time
3.42ms; flip angle 15∘; matrix size 256 × 256; number of slices
176; voxel size 1 × 1 × 1mm3).
2.5. Data Processing and Statistical Analysis. For statistical
analyses of the clinical data, PASW statistics 18 (SPSS Inc.,
Chicago, IL) was used. To test for changes in tinnitus severity,
an analysis of variance (ANOVA) with the within-subjects
factor time (baseline, day 12, day 90) was calculated for
both the TQ and the loudness scale. In case of significant
results, post hoc paired 𝑡-tests were done. For the group of 36
patients with only two assessments, paired 𝑡-tests were used
to compare the TQ and loudness on baseline and day 12. All
statistical tests were two-tailed. The level of significance was
set at .05.
Processing and statistical analysis of the anatomical
data were performed with the SPM8 software package
(Statistical Parametric Mapping, Wellcome Trust Centre
for Neuroimaging; http://www.fil.ion.ucl.ac.uk/spm/). All
anatomical images were visually examined for the pres-
ence of morphological abnormalities or artifacts. Prepro-
cessing of the anatomical data was done using the stan-
dard procedure of the voxel based morphometry tool-
box (VBM8 version 435, Structural Brain Mapping Group;
http://dbm.neuro.uni-jena.de/vbm/) for longitudinal data
and involved intrasubject realignment, bias correction, seg-
mentation, and normalization to the Montreal Neurological
Institute (MNI) space. The default options of the standard
procedure were not changed. As modulation is not necessary
for longitudinal data, unmodulated images were used. After-
wards, a quality check was done using VBM8 before smooth-
ing data with a Gaussian kernel of 8mm full width at half
maximum. Only grey matter images were used for further
analyses. For the statistical analyses all voxels with a greymat-
ter value below 0.1 were excluded to avoid edge effects around
the border between grey and white matter. All analyses were
done for the overall group of 77 patients (baseline and day
12 scans) as this group provided the highest statistical power.
Additionally, all analyses were also done for the independent
subgroups with two (𝑛 = 36) and three (𝑛 = 41) MRI scans.
The following whole-brain analyses were performed.
(1) Grey matter images acquired at every time point were
compared by estimating a flexible factorial model in SPM8
with the factors subject and time (baseline, day 12, and day
90).
(2) To test for correlations between the grey matter chan-
ges over time and changes in the clinical outcome parameters,
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difference images were calculated using the image calculator
implemented in SPM8 (day 12-baseline; day 90-baseline) and
correlated with the corresponding difference in the TQ and
loudness scores.
(3) To find out whether grey matter images might be
useful as a predictor for clinical outcome, baseline images
were correlated with the difference in the TQ score (day 12-
baseline). Please see Table 2 for an overview of all analyses
done.
(4) For all analyses, the significance threshold was set
to 𝑃 < .001 (uncorrected) at voxel level and 𝑃 < .05
(familywise error (FWE) corrected) at cluster level. Due to
the nonisotropic smoothness of VBM data, correction for
nonstationarity was applied. Anatomical Automatic Labeling
(AAL; [41]) and the SPM Anatomy Toolbox [42] were used
for anatomic labeling of significant clusters.
3. Results
3.1. Clinical Outcome. The paired 𝑡-tests comparing the TQ
and the loudness differences between baseline and day 12 in
the overall group of 77 patients revealed a significant decrease
in the TQ score (𝑡(76) = 2.474, 𝑃 = .016) and a marginally
significant decrease in the loudness rating (𝑡(76) = 1.745, 𝑃 =
.085). The paired 𝑡-tests comparing the TQ and the loudness
differences between baseline and day 12 in the subgroup with
only two scans (𝑛 = 36) revealed a significant decrease in the
TQ score (𝑡(35) = 2.292, 𝑃 = .028) and no significant change
in the loudness rating (𝑡(35) =−0.099,𝑃 = .922).TheANOVA
comparing the TQ scores of the subgroup with three scans
(𝑛 = 41) revealed no significant effect of time (𝐹(1.70, 67.82) =
1.743, 𝑃 = .187). The ANOVA comparing the loudness scores
of all three time points suggested a significant difference
between at least two time points (𝐹(2, 80) = 3.522, 𝑃 = .034).
Post hoc paired 𝑡-tests revealed a significant decrease from
baseline to day 12 (𝑡(40) = 2.529, 𝑃 = .015) and a marginally
significant decrease from baseline to day 90 (𝑡(40) = 2.007,
𝑃 = .052). There was no significant change from day 12 to
day 90 (𝑡(40) = −0.371, 𝑃 = .713). See Figure 1 for a line chart
showing the development of the TQ and loudness scores over
time.
3.2. VBM. (1) The flexible factorial models revealed signif-
icant grey matter concentration decreases from baseline to
day 12 in the left and right insula as well as in the left and right
inferior frontal gyrus (please see Figure 2 andTable 3 forMNI
coordinates and statistical details). These GM changes were
visible in both the 𝑛 = 41 and the overall patient sample with
77 patients. It was not detected in the 𝑛 = 36 sample though. If
data of this groupwas analyzed with amore relaxed statistical
threshold (𝑃 < .05 (uncorrected) at voxel level and 𝑃 < .05
FWE corrected at cluster level), GM decreases were found in
the right inferior frontal gyrus (𝑥 = 40, 𝑦 = 39, and 𝑧 = 19;
𝑍 = 3.07, 𝑃 = .059). Please see Figure 3 for the mean GM
concentration of the relevant clusters for all groups and all
time points.
In addition, grey matter decreases were found in the left
temporal pole and the left ventromedial prefrontal cortex.
These GM changes were only visible in the 𝑛 = 41 sample
though. The contrast between baseline and day 12 in the
overall patient sample (𝑛 = 77) additionally revealed
decreased GM in the left inferior/medial temporal gyrus
(Table 3). This was also visible in the 𝑛 = 41 group (𝑥 = −62,
𝑦 = −36, and 𝑧 = −20; 𝑍 = 4.08, 𝑃 = .016) if analyzed with
a more relaxed statistical threshold (𝑃 < .001 (uncorrected)
at voxel level and uncorrected at cluster level). In the 𝑛 = 36
group, no significant GM decreases were visible. Overall, no
grey matter increases from baseline to day 12 were visible in
neither group. Neither grey matter increases nor decreases
were found from baseline to day 90.
(2) The correlation analyses between the difference
images and the difference in theTQ/loudness ratings revealed
no significant results.
(3) The correlation analyses between the TQ difference
and the baseline images revealed a positive correlation of the
TQ with GM concentration in the left medial temporal pole
and the right posterior cingulate cortex in the 𝑛 = 36 group
(Table 3). The correlations in the 𝑛 = 41 group did not reach
statistical significance. Furthermore, in the overall patient
group, a positive correlation between the TQ difference
and the baseline images was found in the left and right
lingual gyrus. Additionally, a marginally significant positive
correlation was detected in the right inferior/middle frontal
gyrus. Using a more relaxed statistical threshold (𝑃 < .05
(uncorrected) at voxel level and 𝑃 < .05 FWE corrected at
cluster level), a marginally positive correlation in the lingual
gyrus (𝑥 = −4, 𝑦 = −91, and 𝑧 = 13; 𝑍 = 3.78, 𝑃 = .064)
and in the inferior/middle frontal gyrus (𝑥 = 40, 𝑦 = 44, and
𝑧 = 21; 𝑍 = 3.34, 𝑃 = .093) was also found in the 𝑛 = 41
group.
4. Discussion
In order to improve rTMS treatment for patients suffering
from subjective tinnitus, it is of particular importance to
understand the neural alterations rTMS induces in tinnitus
patients’ brains in general and in treatment responders’
brains in particular. The current study aimed at investigating
the structural brain changes after rTMS treatment and the
connection between these changes and clinical outcome. We
examined grey matter alterations after ten sessions of low-
frequency rTMS of the left temporal cortex. Besides the result
that tinnitus severity and loudness were significantly reduced
after rTMS treatment, the main findings of the present study
were the following. (1) Transient GM decreases from baseline
to day 12 were observed in several cortical areas. Neither
GM increases nor GM changes from baseline to day 90 were
detectable. (2)There was no correlation betweenGMchanges
and clinical outcome. (3) GM images at baseline correlated
with treatment outcome suggesting thatGMat baselinemight
be related to treatment response.
4.1. Grey Matter Changes from Baseline to Day 12. Bilateral
GM decreases from baseline to day 12 were detectable in the
insula and the inferior frontal gyrus (IFG).Those results were
identical in the 𝑛 = 41 group and the overall patient sample.
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Table 2: Overview over all VBM analyses.
Research question Statistics
𝑛 = 41
(3 scans)
𝑛 = 36
(2 scans)
𝑛 = 77
(whole group 2 scans)
(1) Grey matter changes
after rTMS?
Flexible factorial models with factors subject + time
Time points:
baseline, day 12, day 90
Time points:
baseline, day 12
Time points:
baseline, day 12
(2) Correlation between
grey matter changes and
clinical outcome
parameters?
Correlation of difference in the TQ/loudness rating with difference images
Time difference:
day 12–baseline
day 90–baseline
Time difference:
day 12–baseline
Time difference:
day 12–baseline
(3) Grey matter as predictor
for treatment response? Correlation of difference in the TQ with baseline images
On a more relaxed statistical threshold, the GM decreases in
the right inferior frontal cortex were also visible in the 𝑛 = 36
group. As it can be seen in Figure 3, this group also shows
the tendency for GM decreases in both the right and left
insula/frontal cortex. However, the difference is too small to
reach statistical significance. Together with the anterior parts
of the insula, the IFG is supposed to be a part of the ventral
attention network (VAT), a mostly right-lateralized network
responsible for a stimulus-driven “bottom-up” reorientation
of attention to salient stimuli [43]. An altered connectivity
between the VAT and the auditory and visual cortices in
patients with bothersome tinnitus has recently been shown
[44]. Furthermore, the insula has been reported to be part of
a salience network [45], and both the IFG and the anterior
insula are supposed to be involved in conflict processing
[46]. If tinnitus is perceived as a permanent salient stimulus,
it continuously attracts attention and conflicts with other
salient stimuli. It is therefore not surprising that, as part of the
VAT, alterations in the structure [15, 47] and function [10] of
the IFG have been repeatedly reported in tinnitus research.
While the insula is also a part of the VAT, it additionally plays
an important role as part of a nonspecific distress network
[11]. A relation between the insula and tinnitus distress has
been consistently found in EEG studies [48, 49] and in studies
examining structural brain alterations; decreasedGMvolume
in the insula was reported in highly distressed patients [13] as
well as a positive correlation between tinnitus distress and the
cortical thickness in the anterior insula [19].
Notably, the GM decreases in the IFG and the insula
seen in the current study were observed for the whole group
independently of treatment outcome, indicating that these
changes are rather related to the intervention than related
to its clinical effect. The same is true for the remaining GM
decreases observed.WhileGMalterations in the left temporal
pole and the ventromedial prefrontal cortex were only visible
in the small sample and are therefore not further discussed,
the GM decrease in the inferior and middle temporal gyrus
was only seen in the overall sample and—on a more relaxed
statistical threshold—in the 𝑛 = 41 sample. Again, the 𝑛 = 36
sample showed the same tendency (see Figure 3) but not in
a significant degree. Similar to the IFG and the insula, the
medial temporal cortex has been previously reported to show
functional alterations in tinnitus patients [10, 50]. However,
GM changes in the medial temporal cortex might be rather
linked to hearing loss than linked to tinnitus [14] and the
same might be true for the inferior temporal cortex. Again,
the morphological changes observed in the current study are
not correlated with changes in the TQ or loudness scores.
These results clearly suggest that rTMS leads to GM changes
indeed but that these changes are an expression of “treatment”
rather than an expression of “treatment outcome.” All in all,
those results are to be seen as preliminary and replications
are clearly needed as the GM decreases were only statistically
significant in the overall sample and one subsample but not
in the second, smaller subgroup of 36 patients.
Besides the GM decreases reported above, no grey matter
increases were found from baseline to day 12—a finding
which is not in line with the results of May et al. [30] who
found GM increases in the left superior temporal area after 5
days of rTMS stimulation of the temporal cortex.The absence
of such a GM increase in the current study is presumably
not a problem of too little statistical power as it was found
neither in the subsamples nor in the larger sample with 77
patients. One of the main differences between the current
study and the study of May et al. is that the latter applied
rTMS to healthy subjects while we used rTMS as a treatment
for patients with subjective tinnitus. Maybe, tinnitus brains
react differently to low-frequency magnetic stimulation in
comparison to control subjects. Knowing that there are both
structural and functional alterations in the tinnitus brain in
comparison to healthy controls [8, 9] and knowing that the
effect of 1Hz-rTMS is state-dependent [26, 51] the different
study outcomes might be reconcilable.
4.2. Grey Matter Changes from Baseline to Day 90. Interest-
ingly enough, no GM decreases (nor increases) were seen
from baseline to day 90 which suggests that the decreases
seen on day 12 are temporary in nature. This observation is
in line with the results of May et al. who also found that the
changes induced by rTMS are transient [30]. It remains to be
seen at which point in time the regression of the GM changes
happens exactly.Whether the observed transient nature of the
rTMS effect on GM may also reflect a transiency of clinical
effects of rTMS treatment should be explored in further
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Figure 1: Line chart showing the time course of the TQ scores and the loudness ratings for both independent subgroups and the overall
group.
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Figure 2: Grey matter decreases from baseline to day 12 in (a) the
right and left inferior frontal gyrus and (b) the insula bilaterally. (c)
Positive correlation of the TQ difference with the GM concentration
at baseline in the right frontal gyrus.
studies. Notably, previous long-term follow-up investigations
in tinnitus patients have suggested long-lasting effects over
periods of up to four years in themajority of rTMS responders
[52, 53].
4.3. Grey Matter Changes and Clinical Outcome. Obviously,
rTMS treatment of the temporal cortex leads to alterations
in cortical regions known to be important for subjective
tinnitus. These alterations do not seem to directly cause
change in tinnitus distress though. As we investigated 77
patients, the lacking correlations do probably not arise from
too little statistical power. Rather, it has to be considered that
VBM might not be a method sensitive enough to capture
neural changes that are related to the slight change of tinnitus
distress or loudness which can be obtained using rTMS.
This might be different for TMS treatment protocols with
larger treatment effects and this might also be different for
neuroimaging methods more sensitive to function rather
than structure—such as fMRI or EEG. The only study
investigating functional changes induced by rTMS using
fMRI measurements could in fact not detect a relationship
between changes in brain activity and clinical outcome [26].
However, with only six patients the study might have lacked
the required power to detect such an effect.
Taken together, the key message is that rTMS treatment
of tinnitus patients affects brain structures different to the
stimulation site which points to the importance of inter-
connections between distant cortical areas. It is well-known
that TMS effects are not limited to the stimulated area and
that functional changes can also be seen in remote cortical
brain areas [54, 55]. What is true for functional changes
might also be right for structural changes. While May et al.
[30] found GM increases in the stimulated area, they also
reported the trend of GM increases in the temporal cortex
contralateral to the stimulation site as well as in the thalamus
bilaterally. Together with the results of the current study this
emphasizes the importance of having in mind that magnetic
stimulation of one cortical hotspot results in functional and
presumably also structural alterations in a whole network of
interconnected areas.
In summary, the bilateral alterations in the IFG and
insulae after rTMS, although not seen on a significant level
in the 𝑛 = 36 group subgroup, further support the notion of
functional connectivity between the left temporal cortex and
the ventral attention network in tinnitus patients. Whereas
rTMS induces transient alterations in these areas and also in
the inferior andmedial temporal cortex, these changes do not
determine the clinical effects.
Neural Plasticity 7
Table 3: Results of all VBM analyses.
Laterality Anatomical region Cluster size in voxels MNI coordinates Peak voxel
𝑍-score
Cluster level
𝑃 value𝑥 𝑦 𝑧
GM decrease from baseline to day 12 (𝑛 = 41)
L Temporal pole, insula, and inferior frontal gyrus 1121 −56 8 −18 4.93 <0.001
R Insula (extending into temporal pole) 565 33 10 −18 4.79 0.001
R Inferior frontal gyrus 475 51 33 12 4.49 0.009
L Ventromedial prefrontal cortex 355 −4 52 −8 3.72 0.026
GM decrease from baseline to day 12 (𝑛 = 77)
L Inferior frontal gyrus, insula 1439 −46 12 −5 4.41 <0.001
R Insula (extending into temporal pole) 684 42 16 −11 4.44 0.001
R Inferior frontal gyrus 616 51 34 12 4.74 0.001
L Inferior/medial temporal gyrus 558 −57 −42 −17 4.21 0.045
Positive correlation of TQ difference with baseline images (𝑛 = 36)
L Medial temporal pole 460 −32 6 −33 4.67 0.014
R Posterior cingulate cortex 430 6 −45 31 4.19 0.036
Positive correlation of TQ difference with baseline images (𝑛 = 77)
R + L Lingual gyrus 534 4 −72 0 4.49 0.037
R Inferior/middle frontal gyrus 413 52 30 19 3.86 0.089
FWE-corrected at cluster level 𝑃 < 0.05.
L, left; R, right; MNI, Montreal Neurological Institute.
4.4. Baseline Grey Matter Images as Predictor for Treatment
Outcome. Concerning the question whether grey matter
images can serve as predictors for treatment response, the
current results suggest that there are some cortical areas in
which patients who will benefit from rTMS treatment have
less GM at baseline than patients who will not benefit. In
the right IFG and the lingual gyrus bilaterally, a positive
correlation between GM at baseline and the TQ change
was detected which means that an improvement in the TQ
(implicated by negative values) is related to less GM at
baseline. These results were seen in the overall patient group
and in tendency also in the 𝑛 = 41 group. Though a positive
correlation was also found in the left medial temporal pole
and the right posterior cingulate cortex, these results were
only visible in the 𝑛 = 36 sample and are therefore not further
discussed. As mentioned above, the right IFG is part of the
VAT and important for attention shifts to salient stimuli.
The question arises however, what “reduced GM volume in
the right IFG” actually means in terms of the function of
the VAT. One could speculate that the VAT had been less
sensitive to salient stimuli (e.g., the tinnitus) prior to rTMS
treatment. As a consequence, a reduction of tinnitus severity
might have been easier to accomplish in those patients. This
is speculation though and—after replication—a challenging
question for future research.The lingual gyrus has never been
reported to play an important role for subjective tinnitus.
However, functional and structural alterations in nearby
occipital regions have been observed in tinnitus patients [14,
56], even if one of those studies suggests that GMdecreases in
occipital regions might be rather due to hearing loss than due
to tinnitus [14]. Overall, these findings have to be considered
as preliminary as the mentioned correlations reached statis-
tical significance only in the overall patient group but not in
the two independent subsamples. Therefore, replications are
needed to confirm those results. Furthermore, there is some
evidence that patients who benefitted from treatment once
also benefit from a second treatment phase [57–59]. For that
reason, future studies should also try to shed light on the
question whether there are characteristics in the brain which
predispose an individual to benefit from rTMS treatment in
general while others do not.
4.5. Limitations. The current study has a number of limi-
tations which should be considered in future studies. First,
as just mentioned, hearing level was not available for all
patients and could therefore not be integrated in the analyses.
Although hearing loss is not supposed to be a predictor
for response to rTMS treatment [24], previous studies have
shown that hearing loss is an important confounder con-
cerning GM changes in tinnitus patients [14, 60, 61]. To be
able to thoroughly interpret research results, future work
should try to include pure tone audiogram including high
frequency audiogram [14, 60, 61] for all patients. Second,
the lacking correlation between treatment outcome and GM
changes might have been due to the small treatment effects.
As already known from previous studies, the effect of rTMS
treatment is small. Therefore, an even higher number of
patientsmight have been necessary to ensure sufficient power
for all analyses. The third and main limitation of the current
study is the lack of a placebo condition. Without a patient
group treated with sham stimulation we cannot definitely
determine whether the observed GM changes were specific
to rTMS treatment or unspecific effects. In the study of
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Figure 3: Mean grey matter concentration for each time point for the clusters with significant GM changes in (a) the subgroup of 41 patients
and (b) the total group of 77 patients. For the clusters of (b) the mean GM concentration is also shown for the two independent subgroups.
May et al. [30], healthy control subjects showed no GM
changes after sham rTMS as opposed to subjects treated with
active rTMS.This finding has not been replicated for tinnitus
patients yet.
5. Conclusions
To the best of our knowledge, this is the first study to combine
clinical assessment and longitudinal structural MRI scans
to measure rTMS effects in tinnitus patients. The major
result of the study is that ten days of low-frequency rTMS
treatment of the temporal cortex leads to transient GM
decreases in cortical regions different from the stimulated
area. This highlights the importance of considering that the
brain is organized in networks and that this organization
highly influences the outcome of an intervention. Transient
GMdecreases were seen bilaterally in the insula, the IFG, and
the left inferior/middle temporal gyrus, indicating functional
connectivity between the stimulation site in the left temporal
cortex and the ventral attention network in tinnitus patients.
Although these cortical areas are known to be important
in the generation and maintenance of tinnitus, the GM
decreases were independent of treatment success. Thus, they
were rather related to the TMS intervention per se and not
to its clinical effect. However, treatment outcome correlated
with GM at baseline indicating reduced GM in the right IFG
and the lingual gyrus in patients benefiting from treatment.
Thus, baseline GM images might hold potential to be further
investigated as predictor for rTMS response in the future.
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